The functional properties of the endothelium of human thyroid arteries remain unexplored. We investigated the intervention of nitric oxide (NO), prostacyclin (PGI 2 ) and endothelium-derived hyperpolarizing factor (EDHF) in the responses to acetylcholine and noradrenaline in isolated thyroid arteries obtained from multi-organ donors. Artery rings were suspended in organ baths for isometric recording of tension. The contribution of NO, PGI 2 and EDHF to endothelium-dependent relaxation was determined by the inhibitory effects of N G -monomethyl--arginine (-NMMA), indomethacin, and K + channel inhibitors respectively. Acetylcholine induced concentrationdependent relaxation; this effect was not modified by indomethacin and was only partly reduced by -NMMA, but was abolished in endothelium-denuded rings. The relaxation resistant to indomethacin and -NMMA was abolished by using either apamin combined with charybdotoxin, ouabain plus barium, or a high-K + solution. Noradrenaline induced concentration-dependent contractions which were of greater magnitude in arteries denuded of endothelium or in the presence of -NMMA.
Introduction
The functional properties of the endothelium-nitric oxide (NO) system of human thyroid arteries remain largely unexplored. Nitric oxide synthase, the enzyme responsible for the formation of NO (Palmer et al. 1988 ) is present in the thyroid follicular cells and in endothelial cells of the human thyroid gland (Colin et al. 1997) , and human thyrocites produce the endogenous NO synthase inhibitor asymmetric-dimethyl--arginine (ADMA; Millatt et al. 2000) . NO production, measured as plasma nitrite-plusnitrate concentrations, is decreased in hyperthyroid patients when compared with controls (Hermenegildo et al. 2002) . Hyperthyroid patients also revealed a significant increase in plasma levels of ADMA. Because ADMA increases the tone of peripheral vessels by inhibiting the basal release of NO from the endothelium (Vallance et al. 1989) , it is conceivable that an increase in ADMA in hyperthyroidism might represent a compensatory mechanism to decrease NO production and, consequently, to counterbalance excessive peripheral vasodilatation (Hermenegildo et al. 2002) . All these results are consistent with a role for NO in the vascular changes observed in thyroid dysfunction.
Receptor-dependent agonists, such as acetylcholine, induce endothelium-dependent smooth muscle relaxation by activating NO synthase and cyclooxygenase to produce NO and prostacyclin (PGI 2 ) respectively (Lüscher & Vanhoutte 1990 , Suzuki & Cheng 1990 , Cohen & Vanhoutte 1995 , Shimokawa & Takeshita 1995 , Vanhoutte 1996 . In addition, after inhibition of NO synthase and cyclooxygenase, stimulation of the endothelium evokes smooth muscle relaxation that has been attributed to a factor called endothelium-derived hyperpolarizing factor (EDHF). Although the nature of EDHF is not known, experimental evidence suggests that the action of EDHF involves activation of endothelial K + channels that are inhibited by the combination of apamin and charybdotoxin (Petersson et al. 1997 , Zygmunt et al. 1997 , Edwards et al. 1998 , Doughty et al. 1999 ). This implicates a role for small-and intermediate-conductance Ca 2+ -activated K + channels (Zygmunt 1996) in endotheliumdependent relaxation. In addition, the release of EDHF leads to activation of smooth muscle inwardly rectifying K + channels and Na + -K + ATP-ase pumps (Edwards et al. 1998) . The aim of the present study was to detect the respective intervention of endothelium-derived NO, PGI 2 and EDHF in the responses to acetylcholine and noradrenaline in human isolated thyroid arteries obtained from multi-organ donors.
Materials and Methods
Glandular branches of the superior thyroid artery were obtained from 14 multi-organ donors during procurement of organs for transplantation (ten men and four women; age range: 22-55 years; cause of death: nine head trauma, three intracranial hemorrhage, two myocardial infarction). The study was approved by the ethical committee of our institution. The vessels were immediately placed in a petri dish containing refrigerated (4 C) modified Krebs-Henseleit solution of the following composition (in mmol/l): NaCl, 115; KCl, 4·6; MgCl 2 {6H 2 O, 1·2; CaCl 2 , 2·5; NaHCO 3 , 25; glucose, 11·1; disodium EDTA, 0·01.
Experiments started within 8 h after organs were removed. Arteries were cleaned of connective tissue and cut into rings (3 mm in length) under a dissecting microscope. In some experiments, the endothelium was removed mechanically by inserting a roughened stainlesssteel wire into the lumen and gently rolling the vessel ring on wet filter paper. Each ring was suspended between two stainless-steel L-shaped pins in 4-ml organ baths containing modified Krebs solution. The solution was equilibrated with 95% oxygen and 5% carbon dioxide to give a pH of 7·3-7·4 and was maintained at 37 C with a circulating water jacket and a heat pump. One pin was fixed to the organ-bath wall and the other was connected to a strain gauge (model FT03; Grass Instrument Division of Astro-Med Inc, West Warwick, RI, USA). Changes in isometric force were recorded on a Macintosh computer (Apple Computer, Cupertino, CA, USA) by use of Chart version 3·4/s software and a MacLab/8e data acquisition system (ADInstruments, Mountain View, CA, USA). To establish the resting tension for maximal force development, we performed a series of preliminary experiments on thyroid artery rings which were exposed repeatedly to 100 mmol/l KCl. Basal tension was increased gradually until contractions were maximal. The optimal resting tension was 1 g. The rings were allowed to attain a steady level of tension during a 2-to 3-h accomodation period before testing. Functional integrity of the endothelium was confirmed routinely by the presence of relaxation induced by acetylcholine (0·1-1 µmol/l) during contraction obtained with noradrenaline (1-3 µmol/l). Arteries in which the acetylcholine reversed the noradrenaline-induced tone by more than 70% were designated as endothelium intact and arteries in which acetylcholine caused less than 15% relaxation were designated as denuded (Martínez et al. 1994 , Medina et al. 1997 .
Relaxations to acetylcholine (1 nmol/l to 1 µmol/l) were investigated in arteries precontracted with noradrenaline to 40-60% of the contraction induced by 100 mmol/l KCl under the following conditions: (1) in the absence of inhibitors (control response); (2) in the presence of indomethacin (10 µmol/l) to inhibit the production of PGI 2 ; (3) in the presence of indomethacin and N G -monomethyl--arginine (-NMMA, 100 µmol/l) to inhibit the production of PGI 2 and NO synthase respectively; (4) in the presence of indomethacin, -NMMA and KCl (20 mmol/l) to inhibit the production of PGI 2 , NO synthase and K + channel activity respectively. To examine the nature of K + channel activation, concentrationresponse curves to acetylcholine were established in the presence of indomethacin plus -NMMA combined with one of the following inhibitors: iberiotoxin (0·1 µmol/l), an inhibitor of large-conductance Ca 2+ -activated K + channels; charybdotoxin (0·1 µmol/l), an inhibitor of both large-and intermediate-conductance Ca 2+ -activated K + channels; apamin (1 µmol/l), an inhibitor of smallconductance Ca 2+ -activated K + channels, and glibenclamide (10 µmol/l), a selective blocker of ATP-sensitive K + channels. Control (in the absence of inhibitors) and experimental (after incubation for 20 min with inhibitors) responses were obtained from separate preparations. In another set of experiments, we determined the effects of barium alone (3 µmol/l, a blocker of inwardly rectifying K + channels) or combined with ouabain (1 mmol/l, an inhibitor of Na + -K + -ATPase). Concentration-response curves for noradrenaline were determined in the absence and in the presence of -NMMA (100 µmol/l) in separate vascular preparations with or without endothelium.
Chemicals
All substances were purchased from Sigma.
Data analysis
All values are expressed as means ... Contractile effects were expressed as a percentage of the response to KCl (100 mmol/l). Relaxation was expressed as a percentage of inhibition of noradrenaline-induced contraction. The concentrations of agonist producing half-maximum effect (EC 50 values) were expressed as pD 2 ( log EC 50 ). The pD 2 values were compared by an unpaired t-test and two-way ANOVA. n values are presented as the number of donors. Statistical significance was accepted at P,0·05.
Results
Acetylcholine caused concentration-dependent relaxations in arteries with an intact endothelium (Fig. 1) . This relaxant effect was not modified by indomethacin and only partly reduced by -NMMA (P,0·05), but was abolished in endothelium-denuded rings (Fig. 1, Table 1 ).
The remaining endothelium-dependent maximal relaxation (Emax), resistant to indomethacin and NO synthase inhibition, was further reduced by pretreatment with 20 mmol/l KCl or the combination of charybdotoxin and apamin ( Fig. 2 ; before treatment: pD 2 7·33 0·20, E max 72 5%; after KCl: pD 2 7·30 0·13, P.0·05, E max 23 3%, P,0·05; after charybdotoxin plus apamin: pD 2 7·45 0·20, P.0·05, E max 27 4%, P,0·05). Incubation with charybdotoxin or apamin alone, or the combination of apamin and iberiotoxin, did not change the acetylcholine-induced relaxation significantly (P.0·05; Fig. 2 ). Glibencamide, a blocker of ATP-sensitive K + channels, had no significant effect on acetylcholineinduced relaxation (data not shown).
The relaxation to acetylcholine in arteries exposed to -NMMA plus indomethacin was slightly decreased in the presence of barium ( Fig. 3 ; before barium: pD 2 7·33 0·20, E max 72 5%; after barium, pD 2 7·15 0·30, P.0·05, E max 43 6%, P,0·05). In the presence of barium plus ouabain the relaxation to acetylcholine was further reduced (E max 12 6%, P,0·05). There was no significant difference in the contractile response to 100 mM KCl between intact and endothelium-denuded artery rings (2162 270 vs 2475 225 mg, n=6 for each group, P.0·05). Noradrenaline produced concentration-dependent contractions which were of greater magnitude in arteries without endothelium (Fig. 4, Table 1 ). Treatment with the NO synthase inhibitor -NMMA induced a parallel leftward shift (about 3 times) (P,0·05) of the response to noradrenaline in arteries with endothelium and did not modify significantly (P.0·05) the concentration-response curve to noradrenaline in arteries without endothelium (not shown). The potentiation induced by -NMMA in arteries with endothelium was completely reversed by -arginine (1 mmol/l, Fig. 4) .
Discussion
The present study in human thyroid arteries demonstrates that the endothelium modulates the responses to acetylcholine and noradrenaline. The relaxation to acetylcholine appears to be endothelium dependent because mechanical removal of the endothelium inhibited the response. The findings of the present study indicate that the order of pD 2 values for noradrenaline and acetylcholine in thyroid arteries corresponds to those determined in other human arteries (Martínez et al. 1994 , Medina et al. 1997 , Segarra et al. 2002 .
Treatment with -NMMA, an inhibitor of NO synthase (Rees et al. 1989 (Rees et al. , 1990 reduced the relaxation to acetylcholine in arteries with endothelium thus indicating the intervention of NO in this effect. However, the NO component, sensitive to -NMMA, accounted for only 20% of the maximum relaxation to acetylcholine. Moreover, treatment with the cyclooxygenase inhibitor indomethacin did not change the endothelium-dependent relaxation, indicating that PGI 2 does not modulate the relaxation response under these conditions. Therefore, the remaining relaxation, insensitive to -NMMA and indomethacin, appears to be the major component of endothelium-dependent relaxation. This NO/PGI 2 -independent relaxation may result from the release by acetylcholine of EDHF (Feletou & Vanhoutte 1988 , Taylor & Weston 1988 . The large EDHF-induced relaxation in response to acetylcholine observed in the thyroid artery is comparable to that shown in the radial artery (Segarra et al. 2000) and in subcutaneous resistance arteries (Coats et al. 2001) .
There is no clear agreement on the identity or the mechanisms by which EDHF relaxes vascular smooth muscle. In humans, the existence of EDHF has been demonstrated in vitro and in vivo (Urakami-Harasawa et al. 1997 , Miura et al. 1999 , Coats et al. 2001 , Katz & Krum 2001 . Several candidates for EDHF have been proposed including endothelium-derived K + ions (Edwards et al. 1998) , epoxyeicosatrienoic acid (Campbell et al. 1996 , Fisslthaler et al. 1999 hydrogen peroxide (Matoba et al. 2000 , 2002 , Yada et al. 2003 ), anandamide (Randall et al. 1996 and C-type natriuretic peptide (Chauhan et al. 2003) . Experimental evidence in small arteries suggests that receptor-dependent agonists, such as acetylcholine, may induce the release of EDHF by opening endothelial K + channels that are sensitive to charybdotoxin plus apamin but are unaffected by iberiotoxin alone or iberiotoxin combined with apamin (Edwards et al. 1998 , Doughty et al. 1999 , Coats et al. 2001 , Scotland et al. 2001 . These results in small arteries indicate that largeconductance, Ca 2+ -activated K + channels are not involved in the acetylcholine-induced release of EDHF. Our results in relatively large human thyroid arteries indicate that the EDHF component involves activation of Ca 2+ -dependent K + channels, sensitive to charybdotoxin and apamin, a finding similar to that observed in human subcutaneous arteries (Coats et al. 2001) .
In certain vascular preparations, EDHF stimulates smooth muscle inwardly rectifying K + channels and Na + -K + -ATPase (Edwards et al. 1998) . This induces hyperpolarization and relaxation. In our experiments, the combination of barium plus ouabain abolished the relaxation resistant to -NMMA and indomethacin. These results indicate that EDHF released by acetylcholine is associated with activation of inwardly rectifying K + channels and Na + -K + -ATPase. We observe that treatment with -NMMA, an inhibitor of NO synthase, augmented the contractile responses to noradrenaline. Inhibitors of NO synthase have been previously reported to increase noradrenaline-induced constriction in several experimental preparations (Angus et al. 1986 , Jones et al. 1993 , Martínez et al. 1994 , Segarra et al. 1999 ). This effect is attributed to the inhibition by -NMMA of the depressant influence of endothelial NO released by noradrenaline through stimulation of 2 adrenoceptors on endothelial cells (Angus et al. 1986) or through indirect mechanisms involving a signal conducted from smooth muscle to adjacent endothelial cells (Dora et al. 1997) . It has been hypothesized that the rise in smooth muscle cell Ca 2+ generates a diffusion gradient that drives Ca 2+ through myoendothelial cell junctions and into the endothelial cells, thereby causing the synthesis of NO (Dora et al. 1997) . It is also possible that the EDHF is also formed after noradrenaline-induced constriction. The study of this possibility has not been attempted in the present report. However, experiments in rat small mesenteric arteries have shown that the release of EDHF can be evoked indirectly by stimulation of 1 adrenergic receptors on the smooth muscle cells (Dora et al. 2000) .
The present results may have implications for understanding how the increased release of endotheliumderived NO and EDHF might affect tissue perfusion in the thyroid gland. Thyroid vascular expansion and endothelial cell proliferation in goitrous rats are significantly inhibited after treatment with the NO synthase inhibitor -NMMA (Colin et al. 1997) , thus suggesting a role for NO in the abnormal vascular changes in thyroid hyperplasia. It remains to be determined whether EDHF, due to its powerful relaxation effects, may represent a novel mechanism for regulating vascularity and maintaining a high tissue perfusion in the thyroid gland.
In conclusion, we have demonstrated that in human thyroid arteries the endothelium significantly modulates responses to acetylcholine and noradrenaline through the release of NO and EDHF. EDHF-mediated relaxation involves activation of charybdotoxin-and apaminsensitive K + channels.
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